Close Menu

NEW YORK – Yourgene Health announced Monday it has received CE-IVD marking for its Illumina-based Iona noninvasive prenatal test for genetic disorders including Down's syndrome.

The Iona Nx NIPT Workflow was developed to run on Illumina's NextSeq 550Dx next-generation sequencing platform and has a new workflow featuring advanced proprietary sample preparation technologies and a simplified test process to reduce the need for instrumentation capital expenditure, the company said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.